Evoke Pharma (EVOK) Institutional Ownership $5.07 -0.42 (-7.65%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Evoke Pharma (NASDAQ:EVOK)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$55.53KNumber ofInstitutional Sellers(last 12 months)0 Get EVOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Evoke Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVOK Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Evoke Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2024 Corsair Capital Management L.P.11,667$56K0.0%N/A1.425% 11/9/2021BlackRock Inc.175,559$228K0.0%+9.2%0.541% 11/2/2021Raymond James Financial Services Advisors Inc.108,545$141K0.0%-8.9%0.335% 8/17/2021 Worth Venture Partners LLC397,742$545K0.2%+18.2%1.229% 8/16/2021 Sabby Management LLC47,431$65K0.0%N/A0.147% 8/13/2021 Geode Capital Management LLC195,760$268K0.0%+22.4%0.605% 8/13/2021 Vanguard Group Inc.1,120,178$1.53M0.0%-1.5%3.460% 8/12/2021 AIGH Capital Management LLC1,701,185$2.33M0.4%+18.7%5.255% 5/20/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/19/2021 Worth Venture Partners LLC336,516$616K0.3%N/A1.040% 5/18/2021 Morgan Stanley723,897$1.33M0.0%+43.6%2.236% 5/18/2021 Jane Street Group LLC18,044$33K0.0%N/A0.056% 5/13/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/12/2021 UBS Group AG31,757$58K0.0%+1,709.5%0.098% 5/7/2021BlackRock Inc.150,891$276K0.0%+8.2%0.466% 4/9/2021 Pure Financial Advisors Inc.17,647$32K0.0%N/A0.055% 2/24/2021 Virtu Financial LLC18,335$47K0.0%N/A0.069% 2/10/2021 Renaissance Technologies LLC187,276$483K0.0%+739.8%0.710% 2/9/2021 Wells Fargo & Company MN25,117$65K0.0%+17,840.7%0.095% 2/5/2021BlackRock Inc.139,474$360K0.0%+8.7%0.529% 11/13/2020 Morgan Stanley92,920$436K0.0%+250.9%0.352% 11/6/2020BlackRock Inc.128,275$601K0.0%-35.7%0.493% (Data available from 1/1/2016 forward) EVOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVOK shares? During the previous two years, the following institutional investors and hedge funds held shares of Evoke Pharma shares: Corsair Capital Management L.P. ($56K).Learn more on EVOK's institutional investors. Which institutional investors have been buying Evoke Pharma stock? The following institutional investors have purchased Evoke Pharma stock in the last 24 months: Corsair Capital Management L.P. ($11.67K). How much institutional buying is happening at Evoke Pharma? Institutional investors have bought a total of 11,667 shares in the last 24 months. This purchase volume represents approximately $55.53K in transactions. Related Companies DRRX Major Shareholders KALA Major Shareholders DARE Major Shareholders FBRX Major Shareholders LGVN Major Shareholders LPCN Major Shareholders NAII Major Shareholders PLUR Major Shareholders LVTX Major Shareholders ENLV Major Shareholders This page (NASDAQ:EVOK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.